Part,  Chapter, Paragraph

 1   II,     5.  3.  2    |              Andalusia and Catalunia), Switzerland, the Netherlands and the
 2   II,     5.  3.  3    |           Luxembourg, the Netherlands, Switzerland).~- The basic mortality
 3   II,     5.  3.  5    |             new cases per 100,000) and Switzerland for women (56 new cases
 4   II,     5.  3.  6    |                the Netherlands, Italy, Switzerland and Spain. Denmark and England
 5   II,     5.  3.  6    |                France, Germany, Italy, Switzerland, the Netherlands and Spain);
 6   II,     5.  3.  6    |              Sweden, France, Italy and Switzerland survival was 80%. England,
 7   II,     5.  3.  7    |              Yes~ICELAND~No~NORWAY~Yes~SWITZERLAND~Yes~Source: Haward R, Borras
 8   II,     5.  5.  2    |           Luxembourg, Malta, Portugal, Switzerland, Turkey and the United Kingdom.
 9   II,     5.  5.  2    |                and in Iceland, Norway, Switzerland and Turkey (Alzheimer Europe,
10   II,     5.  5.  2    |            well as in Norway, Iceland, Switzerland and Turkey. The results
11   II,     5.  5.  2    |   Bundesministerium der Justiz, 2007). Switzerland, the Netherlands and France
12   II,     5.  5.  3    |           Kingdom, Scotland and Wales, Switzerland, Netherlands) emphasise
13   II,     5.  5.  3    |               Scotland, Spain, Sweden, Switzerland, Wales, Denmark, Canada,
14   II,     5.  5.  3    |           Kingdom, Scotland and Wales, Switzerland, Netherlands) emphasise
15   II,     5.  5.  3    |         seizure~ II 60 months (taxi) -~Switzerland I 12 months -~United Kingdom
16   II,     5.  5.  3    |      Association (EFTA) Countries, and Switzerland, hereafter referred to as “
17   II,     5.  5.  3    |        Netherlands, Belgium, Slovenia, Switzerland and Austria, in comparable
18   II,     5.  5.  3    |             Scotland, The Netherlands, Switzerland, Germany, Austria and Portugal (
19   II,     5.  5.  3    |              from Austria, Germany and Switzerland developed and published
20   II,     5.  5.  3    |               500 (Estonia) – €13,000 (Switzerland) with an average cost per
21   II,     5.  6.  6    |                Group. TRS 919. Geneva, Switzerland. Available at URL : ht ~ ~
22   II,     5.  9.  3    |           years of age), Romania (7%), Switzerland (9.1% in children and 6.
23   II,     5.  9.  3    |              Hungary 17%, Romania 15%, Switzerland 14.2% in adults and 17%
24   II,     5.  9.  4    |                    High~Low~High~Low~–~Switzerland~ Basel~Low~–~High~–~–~High~
25   II,     5.  9.  7    |           Epidemiology of allergies in Switzerland. Ther Umsch. May;58(5):253-
26   II,     5. 11.  3    |          Ceylan et al, 2003).~In Vaud, Switzerland, BCC was the most common
27   II,     5. 12.  2    |            Denmark up to 2001, and for Switzerland up to 1992. Data for Croatia
28   II,     5. 14.  8    |              prevention”. WHO, Geneva, Switzerland. [http://www.who.int/gb/
29   II,     5. 14.  8    |             Area Profile. WHO, Geneva, Switzerland. Available at: http://ww l (
30   II,     9            |              15% or over) in Spain and Switzerland (WHO/HSBC, 2004), though
31   II,     9.  1.  2    |               EU-27 countries, Norway, Switzerland, and Croatia participate
32   II,     9.  1.  2    |         Finland, Italy, Spain, Sweden, Switzerland, Czech Republic), while
33   II,     9.  1.  2    |            Table 9.1.2.3). Up to 0.8% (Switzerland) of foetuses die due to
34   II,     9.  1.  2    |               registries in France and Switzerland, where the proportion of
35   II,     9.  2.  4    |              15% or over) in Spain and Switzerland (WHO/HSBC, 2004), though
36   II,     9.  3.  2    |       Netherlands, Slovenia, Spain and Switzerland - the most recent data show
37   II,     9.  3.  3    |               Johnson et al, 2001) and Switzerland (Dubois-Arber et al, 1997).
38   II,     9.  3.  3    |             Italy, the Netherlands and Switzerland) have been recognized, but
39   II,     9.  3.  3    |              the general population in Switzerland. Am J Public Health 87:558-
40  III,    10.  1.  3    |           Health Organization, Geneva, Switzerland.~Meusel D, Maywald U, Hach
41  III,    10.  2.  1    |               Estonia, Spain, Romania, Switzerland, Lithuania, Latvia and Luxembourg,
42  III,    10.  2.  1    |              prevention”. WHO, Geneva, Switzerland. Available at: [http://www.
43  III,    10.  2.  1    |  health-promoting school. WHO, Geneva, Switzerland.~ ~World Health Organization.
44  III,    10.  2.  1    |               Slovenia, Spain, Sweden, Switzerland, The former Yugoslav Republic
45  III,    10.  2.  1    |            Recent studies conducted in Switzerland and the United Kingdom show
46  III,    10.  2.  1    | physical activity: first estimates for Switzerland. Scientific position statement
47  III,    10.  2.  1    |            Zurich and the Network HEPA Switzerland. Schweizerische Zeitschrift
48  III,    10.  2.  1    |                Finland) to seven years(Switzerland). An example is the recently
49  III,    10.  2.  1    |                www.livsmedelsverket.se~Switzerland~Data not available~ ~ ~ ~ ~
50  III,    10.  3.  1    |                Martin et al. 2006). In Switzerland, about 15% of the population
51  III,    10.  3.  2    |              WTO, 2006a). The EU25 and Switzerland together have a 59% share
52  III,    10.  4.  1    |         children. A study conducted in Switzerland also found an increased
53  III,    10.  4.  2    |             other countries, too (e.g. Switzerland, Norway, United Kingdom,
54  III,    10.  4.  5    |                East and Eastern Europe Switzerland and Liechtenstein)~WCE~Western
55  III,    10.  4.  5(42)|         Iceland, Lichtenstein, Norway, Switzerland and Turkey~
56  III,    10.  5.  3    |            Croatia, Turkey, Norway and Switzerland. Among other things participants
57  III,    10.  5.  3(43)|              Germany, Italy, Portugal, Switzerland~
58   IV,    11.  1.  4    |                Germany, Luxembourg and Switzerland (Siciliani and Hurst, 2004).
59   IV,    11.  1.  5    |    Czech Republic, Hungary, Italy, and Switzerland (50% or less). For cervical
60   IV,    11.  1.  5    |          Belgium, Finland, Austria and Switzerland (6.5 and over), the lowest
61   IV,    11.  1.  6    |               by salary~100% by salary~Switzerland~96% by fee-for-service and
62   IV,    11.  1.  6    |               Spain, Slovenia, Sweden, Switzerland (Carrin and Hanvoravongchai,
63   IV,    11.  3.  1    |              Europe, Austria, Germany, Switzerland, and to some extent Belgium
64   IV,    11.  3.  1    |                Italy, Japan, Spain and Switzerland declined. If training efforts
65   IV,    11.  3.  1    |                also growing rapidly in Switzerland, France and some of the
66   IV,    11.  3.  2    |            Norway, Slovakia, Slovenia, Switzerland and Turkey (HFA 2007).~ ~
67   IV,    11.  3.  2    |              other countries (Denmark, Switzerland, Sweden, the Netherlands,
68   IV,    11.  6.  1    |            spending reached in France, Switzerland, Iceland and Portugal to
69   IV,    11.  6.  1    |              in Luxembourg, Norway and Switzerland. Per capita health expenditure
70   IV,    11.  6.  1    |            such as France, Germany and Switzerland do not come close to that
71   IV,    11.  6.  2    |                 Slovakia, Slovenia and Switzerland. Finally there are some
72   IV,    11.  6.  2    |       Luxembourg, the Netherlands, and Switzerland (Saltman 2004). During the
73   IV,    11.  6.  2    |                  Portugal~- Slovenia~- Switzerland~ ~Certain chronic conditions:~-
74   IV,    11.  6.  2    |            Slovenia~- Spain~- Sweden~- Switzerland~- UK~ ~Elderly:~- Belgium~-
75   IV,    11.  6.  3    |              the Netherlands, Germany, Switzerland and the US (Wagstaff et
76   IV,    11.  6.  4    |            Israel, the Netherlands and Switzerland) in 2000 showed that relatively
77   IV,    11.  6.  4    |           previous inpatient diagnosis~Switzerland~93 sickness funds~Joint
78   IV,    11.  6.  4    |               for specialist care) and Switzerland (no regulation). For inpatient
79   IV,    11.  6.  4    |      regulation in France, Germany and Switzerland (Gibis et al, 2004). All
80   IV,    11.  6.  4    |         pharmaceuticals in Austria and Switzerland, and for other services